Drug:
Reaction: ANAEMIA
20250101 - 20251231
No. 201 - 300
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
201 | 25108893 |
RO |
33 | |
HIV-associated neurocognitive disorder, Paresis, Drug resistance, Portal hypertension, Weight decreased, Malabsorption, Ill-defined disorder, HIV infection CDC category C, Interstitial lung disease, Oral candidiasis, Anaemia, |
||||
LOPINAVIR AND RITONAVIR, LAMIVUDINE, LAMIVUDINE ORAL, RALTEGRAVIR, EFAVIRENZ, LAMIVUDINE AND ZIDOVUDINE, |
||||
202 | 25108982 |
FR |
84 | 1 |
Bicytopenia, Confusional state, Anaemia, Thrombocytopenia, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MEROPENEM, LINEZOLID, |
||||
203 | 25109058 |
US |
61 | 2 |
Pancreatic neoplasm, Anaemia, Fatigue, |
||||
PANCRELIPASE, |
||||
204 | 25102472 |
JP |
6 | 2 |
Cerebral infarction, Anaemia, |
||||
ANAGRELIDE HYDROCHLORIDE, |
||||
205 | 25102909 |
US |
||
Nephrolithiasis, Ulcer haemorrhage, Anaemia, Hypotension, Diarrhoea, Blood disorder, |
||||
RIVAROXABAN, |
||||
206 | 25103548 |
RU |
48 | 2 |
Anaemia, Thrombocytopenia, Hepatotoxicity, Disease progression, Metastases to bone, Pleural effusion, Spinal fracture, |
||||
TRASTUZUMAB, PERTUZUMAB, ADO-TRASTUZUMAB EMTANSINE, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, |
||||
207 | 25103663 |
CA |
2 | |
Anastomotic ulcer, Inflammatory marker increased, Dehydration, Blood potassium abnormal, Blood sodium abnormal, Malabsorption, Anaemia, |
||||
RISANKIZUMAB-RZAA, |
||||
208 | 25103848 |
US |
||
Drug reaction with eosinophilia and systemic symptoms, Human herpesvirus 6 infection reactivation, Acute kidney injury, Anaemia, |
||||
ACYCLOVIR, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, METHYLPREDNISOLONE, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
209 | 25103960 |
CN |
56 | |
White blood cell count decreased, Neutrophil count decreased, Anaemia, Myelosuppression, Platelet count decreased, |
||||
OSIMERTINIB, FOLIC ACID, |
||||
210 | 25104006 |
PL |
80 | 2 |
Neutropenia, Anaemia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, LENALIDOMIDE, LENALIDOMIDE, |
||||
211 | 25104536 |
BA |
64 | 2 |
Inflammatory marker increased, Haemorrhage subcutaneous, Bone marrow failure, Neutropenia, Anaemia, Thrombocytopenia, |
||||
ETOPOSIDE, RITUXIMAB, METHYLPREDNISOLONE, CYTARABINE, CISPLATIN, |
||||
212 | 25104658 |
ES |
||
Atrial fibrillation, Erythema nodosum, Neutropenia, Diarrhoea, Aphthous ulcer, Arthralgia, Hypertension, Haemorrhage, Anaemia, |
||||
VENETOCLAX, IBRUTINIB, |
||||
213 | 25104698 |
CA |
||
Acute kidney injury, Liver injury, Pancreatitis, Shunt infection, Status epilepticus, Cardiac murmur, Acute myocardial infarction, Anaemia, Cardiac failure, Drug reaction with eosinophilia and systemic symptoms, Dysphagia, Eosinophilia, Feeding disorder, Hypoalbuminaemia, Inflammation, Jaundice, Troponin increased, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, ALLOPURINOL, CARBAMAZEPINE, CEFTRIAXONE, CEFTRIAXONE SODIUM, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, RIFAMPIN, VANCOMYCIN HYDROCHLORIDE, CEFUROXIME, |
||||
214 | 25105013 |
CN |
65 | 1 |
Syncope, Upper gastrointestinal haemorrhage, Melaena, Anaemia, Asthenia, |
||||
CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
215 | 25105058 |
CA |
68 | |
Anaemia, Fall, Rib fracture, Eye haematoma, Sinusitis, |
||||
PREGABALIN, TIOTROPIUM BROMIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ETANERCEPT, ALBUTEROL SULFATE, GLYCOPYRROLATE, |
||||
216 | 25105334 |
US |
63 | 1 |
Anaemia, Dyspnoea, Fatigue, Adverse drug reaction, |
||||
RIOCIGUAT, RIOCIGUAT, SPIRONOLACTONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, AMMONIUM LACTATE, LACTULOSE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, METOLAZONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ALLOPURINOL, MACITENTAN, ERGOCALCIFEROL, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, DAPAGLIFLOZIN, TORSEMIDE, LORATADINE, LORATADINE ORAL, |
||||
217 | 25105665 |
US |
2 | |
Headache, Arthralgia, Anaemia, |
||||
BEMPEDOIC ACID, |
||||
218 | 25105917 |
BR |
1 | |
Dementia Alzheimer^s type, Anaemia, Memory impairment, Gait inability, Asthenia, |
||||
219 | 25106074 |
JP |
75 | 2 |
Myelosuppression, Anaemia, Platelet count decreased, |
||||
PALBOCICLIB, |
||||
220 | 25106156 |
US |
53 | 1 |
Anaemia, Product use in unapproved indication, |
||||
SPARSENTAN, CLOPIDOGREL, RIVAROXABAN, |
||||
221 | 25106294 |
IT |
86 | 1 |
Drug interaction, Gastric haemorrhage, Melaena, Discoloured vomit, Dyspnoea, Pallor, Pleural effusion, Anaemia, |
||||
FLUCONAZOLE, DABIGATRAN ETEXILATE MESYLATE, DABIGATRAN ETEXILATE, DUTASTERIDE, AMLODIPINE BESYLATE, ALLOPURINOL, URSODIOL, URSOSIOL, CALCITRIOL, |
||||
222 | 25106372 |
IT |
85 | 2 |
Anaemia, Haematochezia, |
||||
ERYTHROPOIETIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RAMIPRIL, ALLOPURINOL, MIRTAZAPINE, DOXAZOSIN MESYLATE, DOXAZOSIN, AMLODIPINE, |
||||
223 | 25106518 |
FR |
60 | 1 |
Anaemia, |
||||
FLUOROURACIL, FLUOROURACIL, CARBOPLATIN, CARBOPLATIN, |
||||
224 | 25106574 |
US |
73 | 2 |
Hydronephrosis, Neutropenia, COVID-19, Headache, Anaemia, |
||||
TRIFLURIDINE AND TIPIRACIL, TRIFLURIDINE AND TIPIRACIL, AMLODIPINE, EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL, MOUTHWASH, MENTHOL, METHYL SALICYLATE, THYMOL, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, EPOETIN ALFA-EPBX, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
225 | 25106615 |
US |
2 | |
Mitral valve disease, Anaemia, |
||||
LECANEMAB, |
||||
226 | 25106653 |
FR |
84 | 1 |
Bicytopenia, Thrombocytopenia, Anaemia, Confusional state, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, LINEZOLID, MEROPENEM, |
||||
227 | 25106770 |
US |
68 | 1 |
Haemothorax, Pleural effusion, Anaemia, |
||||
228 | 25106786 |
AU |
65 | 1 |
Death, Thrombocytopenia, Neutropenia, Anaemia, Acute promyelocytic leukaemia, Second primary malignancy, Haematotoxicity, |
||||
229 | 25106951 |
GB |
1 | |
Anaemia, |
||||
CLOZAPINE, |
||||
230 | 25106980 |
FR |
80 | 2 |
Haematoma muscle, Condition aggravated, Thrombocytopenia, Anaemia, |
||||
APIXABAN, LINEZOLID, DIGOXIN, BISOPROLOL FUMARATE, PANTOPRAZOLE, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
231 | 25107011 |
US |
2 | |
Anaemia, Cough, Exposure during pregnancy, |
||||
USTEKINUMAB, VEDOLIZUMAB, MESALAMINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
232 | 25107058 |
CA |
87 | 1 |
Cardiac failure chronic, Bladder transitional cell carcinoma, Syncope, Disease recurrence, Haemolysis, Acute kidney injury, Skin laceration, Anaemia, Fall, Contusion, |
||||
TAFAMIDIS MEGLUMINE, |
||||
233 | 25107104 |
HU |
73 | 2 |
Pancytopenia, Diarrhoea, Pain, Hepatic enzyme increased, Anaemia, Vomiting, Diarrhoea, |
||||
SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, |
||||
234 | 25107150 |
CA |
2 | |
Death, Inflammatory bowel disease, Diarrhoea, Anaemia, |
||||
ADALIMUMAB-ADAZ, |
||||
235 | 25112660 |
|||
Thrombocytopenia, Anaemia, Anticonvulsant drug level above therapeutic, |
||||
DIVALPROEX SODIUM, |
||||
236 | 25097291 |
US |
63 | 1 |
Anaesthetic complication, Coronary artery disease, Gastric haemorrhage, Feeding disorder, Vomiting, Anaemia, Scar, Procedural complication, Weight decreased, |
||||
ADALIMUMAB, |
||||
237 | 25097379 |
US |
52 | 2 |
Product tampering, Blood pressure increased, Anaemia, Weight increased, Dizziness, Fatigue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
238 | 25097441 |
CA |
91 | 1 |
Anaemia, |
||||
APIXABAN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, LATANOPROST, METOPROLOL TARTRATE, METOPROLOL, |
||||
239 | 25097461 |
US |
63 | 1 |
Hepatic cirrhosis, Ascites, Oesophageal varices haemorrhage, Portal vein thrombosis, Anaemia, Thrombocytopenia, Diverticulum intestinal, Hiatus hernia, Haemorrhoids, Aspartate aminotransferase increased, Alanine aminotransferase increased, Blood thyroid stimulating hormone increased, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, APIXABAN, LEVOTHYROXINE SODIUM, ENTECAVIR, |
||||
240 | 25098048 |
PT |
1 | |
Death, Anaemia, |
||||
PATIROMER, |
||||
241 | 25098270 |
US |
1 | |
Anaemia, Influenza, Asthenia, Drug interaction, |
||||
APIXABAN, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, TAFAMIDIS, SPIRONOLACTONE, EZETIMIBE, FUROSEMIDE, FERROUS SULFATE, EMPAGLIFLOZIN, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, |
||||
242 | 25098375 |
CH |
57 | 2 |
Normochromic normocytic anaemia, Leukopenia, Thrombocytopenia, Anaemia, |
||||
ENTRECTINIB, CEFTRIAXONE SODIUM, CARBOPLATIN, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, REPOTRECTINIB, PEMETREXED, PEMETREXED DISODIUM, MORPHINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, INSULIN GLARGINE, ENOXAPARIN SODIUM, |
||||
243 | 25098563 |
US |
79 | 2 |
Oedema peripheral, Anaemia, Drug ineffective, |
||||
METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, APREMILAST, HYDROXYCHLOROQUINE, SIROLIMUS, AZATHIOPRINE, |
||||
244 | 25098928 |
US |
2 | |
Anaemia, Exposure during pregnancy, |
||||
USTEKINUMAB, USTEKINUMAB, AZATHIOPRINE, VALACYCLOVIR HYDROCHLORIDE, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
245 | 25099452 |
PT |
68 | 1 |
Thrombocytopenia, Anaemia, |
||||
RIFAMPIN, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, GENTAMICIN, GENTAMICIN SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MORPHINE, |
||||
246 | 25099844 |
CN |
63 | 1 |
Gastrointestinal haemorrhage, Asthenia, Decreased appetite, Abdominal distension, Abdominal pain upper, Pyrexia, Hypoproteinaemia, Melaena, Ascites, Anaemia, |
||||
OXALIPLATIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
247 | 25100019 |
RO |
53 | 2 |
Anaemia, Febrile neutropenia, Furuncle, Thrombocytopenia, Bone marrow failure, Rash pruritic, Anal fistula, COVID-19, |
||||
GEMTUZUMAB OZOGAMICIN, CYTARABINE, CYTARABINE, CYTARABINE, AZACITIDINE, AZACITIDINE FOR, ACYCLOVIR, |
||||
248 | 25100208 |
PL |
56 | 1 |
Anaemia, |
||||
CISPLATIN, FLUOROURACIL, |
||||
249 | 25100209 |
PL |
59 | 1 |
Anaemia, |
||||
CISPLATIN, FLUOROURACIL, |
||||
250 | 25100338 |
KR |
12 | 1 |
Leukopenia, Thrombocytopenia, Anaemia, Coagulopathy, Febrile neutropenia, |
||||
VINCRISTINE SULFATE, |
||||
251 | 25100343 |
KR |
10 | 1 |
Leukopenia, Febrile neutropenia, Thrombocytopenia, Anaemia, |
||||
METHOTREXATE SODIUM, CYTARABINE, |
||||
252 | 25100357 |
KR |
6 | 2 |
Leukopenia, Thrombocytopenia, Febrile neutropenia, Anaemia, |
||||
METHOTREXATE SODIUM, CYTARABINE, |
||||
253 | 25100364 |
JP |
8 | 1 |
Death, Nervous system disorder, Decreased activity, Interstitial lung disease, White blood cell count decreased, Neutrophil count decreased, Anaemia, Platelet count decreased, Alanine aminotransferase increased, Blood bilirubin increased, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
254 | 25100441 |
US |
1 | |
Thrombocytopenia, Anaemia, Prostatic specific antigen increased, |
||||
TALAZOPARIB, |
||||
255 | 25100849 |
DE |
82 | 2 |
Groin pain, Cardiogenic shock, Diverticulum intestinal, Left ventricular dysfunction, Femoral hernia incarcerated, Lymphatic fistula, Seroma, Pulmonary hypertension, Hiatus hernia, Inflammatory marker increased, Faecaloma, Arthralgia, Coronary artery disease, Abdominal discomfort, Cardiovascular disorder, Gait disturbance, Hepatic cyst, Mitral valve incompetence, Dyspepsia, Wound infection pseudomonas, Gastrointestinal haemorrhage, Haematuria, Dyspnoea, Eructation, Anaemia, Vomiting, Decreased appetite, Urinary tract infection, Acute kidney injury, Hyperkalaemia, Postoperative wound infection, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, FENTANYL, VALSARTAN, DICLOFENAC, DICLOFENAC SODIUM, BISOPROLOL FUMARATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, AMIODARONE HYDROCHLORIDE, SIMVASTATIN, TORSEMIDE, FOLIC ACID, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
256 | 25101283 |
GB |
2 | |
Respiratory failure, Dyspnoea, Influenza, Malignant neoplasm progression, Breast cancer metastatic, Anaemia, |
||||
RIBOCICLIB, FULVESTRANT, |
||||
257 | 25101339 |
CA |
2 | |
Chronic kidney disease, Anaemia, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
258 | 25101360 |
US |
||
Death, Thrombocytopenia, Neutropenia, Leukopenia, Anaemia, Lymphopenia, Hyperglycaemia, Fatigue, Back pain, Hypocalcaemia, Infusion related reaction, Hypoalbuminaemia, Hyponatraemia, Aspartate aminotransferase increased, Dyspnoea, Headache, Hypophosphataemia, Pyrexia, Pneumonia, Pruritus, Hypertension, Plasma cell myeloma, Encephalopathy, Infection, Sinusitis, Hyperuricaemia, Therapy partial responder, Epistaxis, Chills, Therapy non-responder, Haemorrhage, Diarrhoea, Tachycardia, Nausea, Cough, Wheezing, |
||||
CARFILZOMIB, FILGRASTIM, DARATUMUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BORTEZOMIB FOR INJECTION, BORTEZOMIB, LENALIDOMIDE, POMALIDOMIDE, |
||||
259 | 25101603 |
DE |
1 | |
Thrombocytopenia, Leukopenia, Anaemia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, LENALIDOMIDE, DENOSUMAB, BUDESONIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PAMIDRONATE DISODIUM, ACYCLOVIR, ENOXAPARIN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TORSEMIDE, FOLIC ACID, OXYCODONE, NALOXONE HYDROCHLORIDE, NALOXONE, NALXONE HYDROCHLORIDE, |
||||
260 | 25102004 |
US |
50 | 2 |
Melaena, Anaemia, Dizziness, Gastrooesophageal reflux disease, Hypotension, Helicobacter gastritis, |
||||
APIXABAN, |
||||
261 | 25102020 |
JP |
2 | |
Duodenal ulcer, Enterocolitis, Fistula, Infection, Hypertension, Proteinuria, Anaemia, Pyrexia, Palmar-plantar erythrodysaesthesia syndrome, Malaise, Diarrhoea, Decreased appetite, |
||||
PEMBROLIZUMAB, PACLITAXEL, BEVACIZUMAB, |
||||
262 | 25102069 |
US |
50 | 2 |
Anaemia, Haemorrhoidal haemorrhage, |
||||
APIXABAN, |
||||
263 | 25102258 |
BG |
70 | 2 |
Mitral valve incompetence, Anaemia, Dyspnoea, Cough, Fatigue, Product use issue, Pleural disorder, |
||||
PEMBROLIZUMAB, PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, |
||||
264 | 25104998 |
77 | 1 | |
Gastrointestinal haemorrhage, Red blood cell transfusion, Anaemia, Microcytic anaemia, Duodenal polyp, Large intestine polyp, Small intestine carcinoma, |
||||
APIXABAN, |
||||
265 | 25105176 |
91 | 1 | |
Lower gastrointestinal haemorrhage, Anaemia, Red blood cell transfusion, Therapy interrupted, |
||||
APIXABAN, |
||||
266 | 25105293 |
70 | 1 | |
Anaemia, Gastrointestinal haemorrhage, |
||||
APIXABAN, |
||||
267 | 25092284 |
CA |
2 | |
Administration site rash, Infusion site reaction, Malaise, Infusion site erythema, Pain, Headache, Dermatitis contact, Osteochondroma, Inappropriate schedule of product administration, Injection site paraesthesia, Injection site hypoaesthesia, Anaemia, Paraesthesia, Infusion site pain, Fatigue, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, IVABRADINE, CABERGOLINE, PROMETHAZINE, PANTOPRAZOLE, METOPROLOL TARTRATE, METOPROLOL, |
||||
268 | 25092336 |
BD |
21 | 2 |
Exposure during pregnancy, Anaemia, Live birth, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, NIFEDIPINE, |
||||
269 | 25092353 |
IL |
29 | 2 |
Oligohydramnios, Exposure during pregnancy, Acute kidney injury, Live birth, Vaginal haemorrhage, Anaemia, Thrombocytopenia, Blood lactate dehydrogenase increased, |
||||
ENOXAPARIN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
270 | 25092373 |
CN |
83 | 1 |
Subdural haemorrhage, Anaemia, Haemolysis, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
271 | 25092399 |
NL |
||
Systemic toxicity, Thrombocytopenia, Myelosuppression, Angina pectoris, Neutropenia, Leukopenia, Nausea, Vomiting, Mucosal inflammation, Anaemia, Diarrhoea, Haematotoxicity, Gastrointestinal toxicity, Dysgeusia, Epistaxis, Fatigue, |
||||
PANITUMUMAB, BEVACIZUMAB, FLUOROURACIL, OXALIPLATIN, CAPECITABINE, |
||||
272 | 25092630 |
JP |
||
Ovarian cancer recurrent, Pancytopenia, White blood cell count decreased, Malaise, Abdominal pain upper, Platelet count decreased, Neutrophil count decreased, Anaemia, |
||||
NIRAPARIB, |
||||
273 | 25092774 |
AR |
2 | |
Platelet count decreased, Pneumonia, Pulmonary mass, Haematocrit abnormal, Haemoglobin abnormal, Tumour marker abnormal, Toxicity to various agents, Anaemia, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, LEUPROLIDE, |
||||
274 | 25092798 |
US |
52 | 2 |
Dizziness, Blood pressure increased, Anaemia, Fatigue, Weight increased, |
||||
EMPAGLIFLOZIN, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, IRON, |
||||
275 | 25092949 |
FR |
74 | 1 |
Gastric ulcer, Gastrointestinal haemorrhage, Anaemia, |
||||
PREDNISONE, |
||||
276 | 25093212 |
JP |
68 | 2 |
Malaise, Nausea, Palmar-plantar erythrodysaesthesia syndrome, Diarrhoea, Palmar-plantar erythrodysaesthesia syndrome, Anaemia, Anaemia, Neutrophil count decreased, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
277 | 25093437 |
JP |
29 | 1 |
Platelet count decreased, Neutrophil count decreased, Anaemia, Febrile neutropenia, Scleroderma-like reaction, Pancreatitis, Drug level increased, Drug interaction, Cytomegalovirus infection, Off label use, |
||||
ETOPOSIDE, ETOPOSIDE, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, BLEOMYCIN, BLEOMYCIN SULFATE, CISPLATIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
278 | 25093683 |
US |
37 | 2 |
Pneumonia, Sjogren^s syndrome, Mood altered, Weight increased, Abdominal distension, Arthritis, Postural orthostatic tachycardia syndrome, Anaemia, Nasopharyngitis, Tonsillectomy, Nasal septum deviation, |
||||
AVACOPAN, PREDNISONE, |
||||
279 | 25094276 |
PL |
58 | 2 |
Anaemia, Hypokalaemia, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
280 | 25094309 |
US |
||
Pancreatitis, Anaemia, |
||||
ASFOTASE ALFA, |
||||
281 | 25094420 |
JP |
56 | |
Neutrophil count decreased, White blood cell count decreased, Anaemia, Platelet count decreased, Alanine aminotransferase increased, Nausea, Decreased appetite, Fatigue, |
||||
DURVALUMAB, DURVALUMAB, GEMCITABINE HYDROCHLORIDE, CISPLATIN, |
||||
282 | 25094468 |
US |
2 | |
Anaemia, Illness, |
||||
DUPILUMAB, IRON, HALOBETASOL PROPIONATE, ALBUTEROL SULFATE, HYDROCORTISONE, OIL, BIOTIN, HAIR, OLMESARTAN MEDOXOMIL, |
||||
283 | 25094845 |
61 | 1 | |
Arthralgia, Groin pain, Pain in extremity, Back pain, Abdominal pain, Constipation, Anaemia, Pleural effusion, Chills, Pyrexia, Tremor, Haemangioma of spleen, Infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, MESNA, MESNA INJECTION, METHOTREXATE, METHOTREXATE SODIUM, VINCRISTINE SULFATE, |
||||
284 | 25094860 |
64 | 2 | |
Neutropenia, Myelodysplastic syndrome, Anaemia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, |
||||
285 | 25094998 |
CN |
55 | 2 |
Hyperkalaemia, Leukopenia, Thrombocytopenia, Anaemia, Neutropenia, Myelosuppression, Hyperphosphataemia, Hypoalbuminaemia, Hypomagnesaemia, Hypophosphataemia, Infection, Rash, Blood creatinine increased, Product use in unapproved indication, |
||||
CARBOPLATIN, CARBOPLATIN, CISPLATIN, CISPLATIN, BEVACIZUMAB, |
||||
286 | 25095085 |
JP |
71 | 1 |
Cytokine release syndrome, Atrial fibrillation, Cytomegalovirus infection, Anaemia, |
||||
ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, |
||||
287 | 25095133 |
JP |
41 | 2 |
Premature baby, Malignant neoplasm progression, Maternal exposure during pregnancy, Constipation, Nausea, Alopecia, Anaemia, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, |
||||
288 | 25095322 |
CA |
2 | |
Death, Dementia Alzheimer^s type, Therapeutic drug monitoring analysis not performed, Incorrect dose administered, Anaemia, Off label use, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
289 | 25095702 |
US |
79 | 2 |
Myelosuppression, Thrombocytopenia, Anaemia, |
||||
PALBOCICLIB, |
||||
290 | 25095743 |
TR |
66 | 1 |
Intentional product misuse, Mucosal inflammation, Neutropenia, Leukopenia, Anaemia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
291 | 25095756 |
PL |
31 | 2 |
Anaemia, Haemoglobin decreased, |
||||
RISDIPLAM, |
||||
292 | 25096162 |
IN |
2 | |
Pyrexia, Asthenia, Faeces discoloured, Thrombocytopenia, Anaemia, Intra-abdominal fluid collection, |
||||
CYCLOSPORINE, |
||||
293 | 25096170 |
HU |
2 | |
Death, Fibrosis, Bone marrow disorder, Gastrointestinal haemorrhage, COVID-19, Cytopenia, Jaundice, Anaemia, Hepatosplenomegaly, Monocytosis, Blood lactate dehydrogenase increased, Thrombocytopenia, |
||||
VENETOCLAX, GILTERITINIB, |
||||
294 | 25096172 |
CA |
9 | 2 |
Death, Hypokalaemia, Pulmonary oedema, Pneumonia, Pleural effusion, Hypervolaemia, Dizziness, Hypoaesthesia, Dyspnoea, Abdominal distension, Anaemia, Hypotension, |
||||
SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, MACITENTAN, AMBRISENTAN, TADALAFIL, TADALAFIL, RABEPRAZOLE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, CALCIUM CARBONATE, APIXABAN, ALLOPURINOL, FISH OIL, ERGOCALCIFEROL, |
||||
295 | 25096324 |
BR |
44 | 2 |
Thrombocytopenia, Anaemia, |
||||
RISANKIZUMAB-RZAA, |
||||
296 | 25096557 |
FR |
80 | 2 |
Haematoma muscle, Anaemia, Condition aggravated, Thrombocytopenia, |
||||
LINEZOLID, APIXABAN, DIGOXIN, BISOPROLOL FUMARATE, PANTOPRAZOLE, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
297 | 25096738 |
FR |
74 | 1 |
Thrombocytopenia, Anaemia, Neutropenia, |
||||
TEDIZOLID PHOSPHATE, FOLIC ACID, RIVAROXABAN, RAMIPRIL, BISOPROLOL FUMARATE, LANSOPRAZOLE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ROSUVASTATIN, SPIRONOLACTONE, |
||||
298 | 25097166 |
ES |
2 | |
Intestinal ulcer, Gastric haemorrhage, Anaemia, |
||||
TALQUETAMAB, |
||||
299 | 25097201 |
CA |
78 | 2 |
Chronic kidney disease, Anaemia, |
||||
RISANKIZUMAB-RZAA, |
||||
300 | 25099247 |
48 | 2 | |
Anaemia, Multiple sclerosis relapse, |
||||
INTERFERON BETA-1B, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28